ADMA Biologics, Inc.

ADMA Biologics, Inc.

ADMA Biologics, Inc.

Overview
Date Founded

2006

Headquarters

465 State Route 17 South,Ramsey, NJ 07446-2012

Type of Company

Public

Employees (Worldwide)

314

Industries

Biotechnology

Company Description

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Executives & Employees

Co-Founder

Executive Vice President, Chief Financial & Accounting Officer

Executive Vice President, Chief Scientific Officer & Chief Medical Officer

Co-Founder

Executive Director & Head of Human Resources & Administrative Operations

Vice President, General Counsel

Senior Director, Supply Chain Operations

Senior Director, Adma Biocenters

Senior Director, Analytical & Process Development

Senior Director, Market Access & Reimbursement

Board of Directors

Co-President at Aisling Capital Management LP

Co-Founder at ADMA Biologics, Inc.

Professional at Chimerix, Inc.

Venture Partner at FinHealth Gestão de Recursos SA

Co-Founder at ADMA Biologics, Inc.

Chief Commercial Officer at Kedrion S.p.A.

Paths to ADMA Biologics, Inc.
Potential Connections via
Relationship Science
You
ADMA Biologics, Inc.
Owners & Shareholders
Details Hidden

Founded in 2008, Prosight Management LP is a hedge fund manager located in Dallas, Texas. The firm also does business as Prosight Capital. They manage the Prosight Fund LP.

Details Hidden

Founded in 2008, Prosight Management LP is a hedge fund manager located in Dallas, Texas. The firm also does business as Prosight Capital. They manage the Prosight Fund LP.

Details Hidden

Telemetry Investments allocates capital among multiple strategies to take advantage of market opportunities when prospective returns are compelling. The firm employs the following investment strategies: statistical arbitrage, volatility, convertibles/capital structure, event- driven, long-short, and macro.

Recent Transactions
Details Hidden

ADMA Biologics, Inc. issued USD Common Stock

Details Hidden

ADMA Biologics, Inc. issued USD Common Stock

Details Hidden

ADMA Biologics, Inc. issued . USD Common Stock

Transaction Advisors
Auditor

Advised onADMA Biologics, Inc. issued USD Common Stock

Escrow Agent

Advised onADMA Biologics, Inc. issued USD Common Stock

Underwriter

Advised onADMA Biologics, Inc. issued USD Common Stock

Legal Advisor

Advised onADMA Biologics, Inc. issued USD Common Stock

Managing Director

Advised onADMA Biologics, Inc. issued . USD Common Stock

Managing Director

Advised onADMA Biologics, Inc. issued USD Common Stock

Advisors & Consultants
Legal Advisor

Partner at Dentons

Publicist

Managing Director at Argot Partners LLC

Clients

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company is headquartered in Chesterbrook, PA.

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Key Stats and Financials As of 2019
Market Capitalization
$250M
Total Enterprise Value
$275M
Earnings Per Share
$-0.89
Net Profit
$-48.3M
EBITDA
$-38.2M
EBITDAMargin
-130.04%
Total Debt
$84.7M
Total Equity
$26.2M
Enterprise Value / Sales
9.38x
TEVNet Income
-5.7x
Debt TEV
0.31x
Three Year Compounded Annual Growth Rate Of Revenue
40.15%
Five Year Compounded Annual Growth Rate Of Revenue
37.76%
Revenue
$29.3M
Non-Profit Donations & Grants
$50K - $100K
2017
Suppliers
Grifols SA Biotechnology | Barcelona, Spain

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Competitors
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals - Osaka, Japan

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Grifols SA Pharmaceuticals - Barcelona, Spain

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

CSL Limited Biotechnology - Parkville, VIC

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ADMA Biologics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ADMA Biologics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ADMA Biologics, Inc..